课题基金 / 基金详情

NOVEL ANTIMUTAGENIC COMPOUNDS

NOVEL ANTIMUTAGENIC COMPOUNDS
新型抗突变化合物
批准号:
3186006
负责人:
Lester A. Mitscher
金额:
$19.84万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-04-01 至 1993-03-31

项目摘要

项目成果

Lester A. Mitscher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have undertaken a study of novel naturally occuring antimutagenic agents. Antimutagens are individual chemical compounds that decrease the numbers of spontaneous or injury- induced mutations in intact cell populations. This proposal is to use short-term tests to screen for; isolate by use of bioassay directed methodology; determine chemical structure by spectroscopic and wet chemical methodology of; determine structure-activity relations by systematic syntheses and chemical transformations of; explore the biological properties of; and explore the molecular mechanisms of action of novel antimutagens of natural origin. The long-term objectives are to make potential chemopreventive agents against genetic damage and, perhaps, cancer. Using a bioassay specially developed for the purpose, Glycyrrhiza glabra, a well known plant used by humans since ancient times for its flavoring and medicinal properties, was shown to be reproducably active. The activity was present in the phenolic fractions and, after chromatographic resolution, the flavanoids glabrene and, to a lesser extent, glabridin and glabrol, were found to be the active constituents. The bioassay which produced these successful results in this trial study is based upon the well known Ames short-term Salmonella mutagenicity assay but modified through the use of an alkylating agent (ethyl methanesulfonate) to induce mutations. Based upon this success, it is proposed to use the screen, with the inclusion of other mutagenic treatments as well, to screen for additional examples of natural antimutagenic substances in related plants and to identify the active constituents. A program of chemical modification accompanied by biotesting is proposed so as to explore in a systematic way the relationship between structure and activity in these novel series. In addition to the insights into the mutagenic phenomenon and the other biological areas where mutagenicity is believed to play an important role (ageing, heredity, carcinogenicity, environmental concerns) these compounds may have some potential in preventive human medicine.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Antimutagenicity of secondary metabolites from higher plants.
高等植物次生代谢产物的抗突变性。
DOI: 10.1016/0027-5107(92)90067-c
发表时间: 1992
期刊: Mutation research
影响因子: --
作者: [Mitscher,LA, Telikepalli,H, Wang,PB, Kuo,S, Shankel,DM, Stewart,G]
通讯作者: Stewart,G
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
  • 批准号:
    7959397
  • 项目类别:
  • 资助金额:
    $31.0万
  • 财政年份:
    2009
  • 负责人:
    Lester A. Mitscher
  • 依托单位:
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
  • 批准号:
    7720081
  • 项目类别:
  • 资助金额:
    $30.55万
  • 财政年份:
    2008
  • 负责人:
    Lester A. Mitscher
  • 依托单位:
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
  • 批准号:
    7609706
  • 项目类别:
  • 资助金额:
    $37.56万
  • 财政年份:
    2007
  • 负责人:
    Lester A. Mitscher
  • 依托单位:
ANTIMYCOBACTERIAL AGENTS FROM HIGHER PLANTS
  • 批准号:
    2004155
  • 项目类别:
  • 资助金额:
    $17.7万
  • 财政年份:
    1995
  • 负责人:
    Lester A. Mitscher
  • 依托单位:
海外基金